Literature DB >> 2653809

N-myc is frequently activated by proviral insertion in MuLV-induced T cell lymphomas.

M van Lohuizen1, M Breuer, A Berns.   

Abstract

We report a new common proviral insertion site in murine leukemia virus-induced T cell lymphomas to be N-myc. Proviral activation of N-myc was found in 35% of independently induced primary tumors. The vast majority of the proviral insertions occur within a small segment of the 3'-untranslated region of the N-myc gene, directly downstream of the protein-encoding domain. This results in an increased level of expression of a truncated N-myc mRNA. Together with the previously shown c-myc activation we now find involvement of myc genes in greater than 75% of the primary T cell lymphomas induced by Moloney murine leukemia virus in C57BL10 and BALB/c mice, and show for the first time that N-myc can be over-expressed by a mechanism other than gene amplification.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2653809      PMCID: PMC400781          DOI: 10.1002/j.1460-2075.1989.tb03357.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  22 in total

1.  Alkaline transfer of DNA to plastic membrane.

Authors:  P Chomczynski; P K Qasba
Journal:  Biochem Biophys Res Commun       Date:  1984-07-18       Impact factor: 3.575

2.  Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region.

Authors:  H T Cuypers; G Selten; W Quint; M Zijlstra; E R Maandag; W Boelens; P van Wezenbeek; C Melief; A Berns
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

3.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.

Authors:  M Schwab; K Alitalo; K H Klempnauer; H E Varmus; J M Bishop; F Gilbert; G Brodeur; M Goldstein; J Trent
Journal:  Nature       Date:  1983 Sep 15-21       Impact factor: 49.962

4.  Activated expression of the N-myc gene in human neuroblastomas and related tumors.

Authors:  N E Kohl; C E Gee; F W Alt
Journal:  Science       Date:  1984-12-14       Impact factor: 47.728

5.  Transposition and amplification of oncogene-related sequences in human neuroblastomas.

Authors:  N E Kohl; N Kanda; R R Schreck; G Bruns; S A Latt; F Gilbert; F W Alt
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

6.  Common sites of viral integration in lymphomas arising in AKXD recombinant inbred mouse strains.

Authors:  M L Mucenski; D J Gilbert; B A Taylor; N A Jenkins; N G Copeland
Journal:  Oncogene Res       Date:  1987

7.  Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations.

Authors:  M Graham; J M Adams; S Cory
Journal:  Nature       Date:  1985 Apr 25-May 1       Impact factor: 49.962

8.  Infection of preimplantation mouse embryos and of newborn mice with leukemia virus: tissue distribution of viral DNA and RNA and leukemogenesis in the adult animal.

Authors:  R Jaenisch; H Fan; B Croker
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

9.  Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas.

Authors:  G Selten; H T Cuypers; A Berns
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

10.  Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation.

Authors:  G Selten; H T Cuypers; M Zijlstra; C Melief; A Berns
Journal:  EMBO J       Date:  1984-12-20       Impact factor: 11.598

View more
  33 in total

1.  Expression of the woodchuck N-myc2 retroposon in brain and in liver tumors is driven by a cryptic N-myc promoter.

Authors:  G Fourel; C Transy; B C Tennant; M A Buendia
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

2.  Activation of Lyt-2 associated with distant upstream insertion of an SL3-3 provirus.

Authors:  D S Anson; K Clarkin; R Hyman
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression.

Authors:  J Couturier; X Sastre-Garau; S Schneider-Maunoury; A Labib; G Orth
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus.

Authors:  C Transy; G Fourel; W S Robinson; P Tiollais; P L Marion; M A Buendia
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

5.  Insertional activation of N-myc by endogenous Moloney-like murine retrovirus sequences in macrophage cell lines derived from myeloma cell line-macrophage hybrids.

Authors:  M Setoguchi; Y Higuchi; S Yoshida; N Nasu; Y Miyazaki; S Akizuki; S Yamamoto
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

6.  Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.

Authors:  Hiroyuki Kawagoe; Gerard C Grosveld
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

7.  Identification of a common viral integration region in Cas-Br-E murine leukemia virus-induced non-T-, non-B-cell lymphomas.

Authors:  D Bergeron; L Poliquin; C A Kozak; E Rassart
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

Review 8.  The use of transgenic mice in unraveling the multistep process of tumorigenesis.

Authors:  M Breuer
Journal:  Radiat Environ Biophys       Date:  1991       Impact factor: 1.925

9.  BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets.

Authors:  S S Clark; E Chen; M Fizzotti; O N Witte; V Malkovska
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  Gene profiling of the erythro- and megakaryoblastic leukaemias induced by the Graffi murine retrovirus.

Authors:  Veronique Voisin; Philippe Legault; Diana Paulina Salazar Ospina; Yaacov Ben-David; Eric Rassart
Journal:  BMC Med Genomics       Date:  2010-01-26       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.